The mRNA expression levels of the OBSCN and ANK1.5 genes, as well as immunofluorescence staining of their products were remarkably reduced in the ARVC group (all P < 0.05, Figure 6E-F). This evidence concerns the gene OBSCN and arrhythmogenic right ventricular cardiomyopathy.